EP2429559A4 - Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition - Google Patents

Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition

Info

Publication number
EP2429559A4
EP2429559A4 EP10771913.0A EP10771913A EP2429559A4 EP 2429559 A4 EP2429559 A4 EP 2429559A4 EP 10771913 A EP10771913 A EP 10771913A EP 2429559 A4 EP2429559 A4 EP 2429559A4
Authority
EP
European Patent Office
Prior art keywords
treatment
inflammation
pain
prevention
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10771913.0A
Other languages
German (de)
French (fr)
Other versions
EP2429559A1 (en
Inventor
Peter Smith
William Anseline
Daryll Ian Knowles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALLMEDIC Pty Ltd
Original Assignee
ALLMEDIC Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009902049A external-priority patent/AU2009902049A0/en
Application filed by ALLMEDIC Pty Ltd filed Critical ALLMEDIC Pty Ltd
Publication of EP2429559A1 publication Critical patent/EP2429559A1/en
Publication of EP2429559A4 publication Critical patent/EP2429559A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP10771913.0A 2009-05-08 2010-05-10 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition Withdrawn EP2429559A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009902049A AU2009902049A0 (en) 2009-05-08 Treatment of pain and/or inflammation
PCT/AU2010/000539 WO2010127411A1 (en) 2009-05-08 2010-05-10 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition

Publications (2)

Publication Number Publication Date
EP2429559A1 EP2429559A1 (en) 2012-03-21
EP2429559A4 true EP2429559A4 (en) 2013-08-14

Family

ID=43049857

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10771913.0A Withdrawn EP2429559A4 (en) 2009-05-08 2010-05-10 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition

Country Status (3)

Country Link
EP (1) EP2429559A4 (en)
AU (1) AU2010244983B2 (en)
WO (1) WO2010127411A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102846860A (en) * 2012-09-07 2013-01-02 叶志群 Medicinal liquor for oral administration for treating wind-heat-lung-attacking-type psoriasis
CN105142728B (en) * 2013-01-30 2020-02-14 波利斯.格林施泰恩 Compositions and methods for treating surface wounds
EP3520818A1 (en) * 2018-02-01 2019-08-07 AC BioScience SA Compositions for treating and /or preventing photodynamic therapy side effects

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004010A1 (en) * 1989-09-12 1991-04-04 Ivy Jeffery W An external analgesic lotion and method of making
US5124320A (en) * 1989-09-12 1992-06-23 Ivy Jeffery W An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion
WO2004010958A2 (en) * 2002-07-31 2004-02-05 Shaklee Corporation A method for maximizing scalp health and inducing enhanced visual and tactile hair quality
JP2006335680A (en) * 2005-06-02 2006-12-14 Gero Kosha:Kk Skin care preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760079A (en) * 1995-05-23 1998-06-02 Dermatology Home Products Inc. Method of applying alpha hydroxy acids for treating striae distensae
CN1202364A (en) * 1997-06-13 1998-12-23 湖南中医学院第一附属医院 Oil solutions for remitting angina pectoris
HU226065B1 (en) * 1997-11-25 2008-04-28 Astellas Pharma Europ B V Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004010A1 (en) * 1989-09-12 1991-04-04 Ivy Jeffery W An external analgesic lotion and method of making
US5124320A (en) * 1989-09-12 1992-06-23 Ivy Jeffery W An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion
WO2004010958A2 (en) * 2002-07-31 2004-02-05 Shaklee Corporation A method for maximizing scalp health and inducing enhanced visual and tactile hair quality
JP2006335680A (en) * 2005-06-02 2006-12-14 Gero Kosha:Kk Skin care preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010127411A1 *

Also Published As

Publication number Publication date
AU2010244983B2 (en) 2015-07-16
EP2429559A1 (en) 2012-03-21
WO2010127411A1 (en) 2010-11-11
AU2010244983A1 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
EP2118300A4 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
EP2429411A4 (en) Methods and devices to treat diseased or injured musculoskeletal tissue
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
IL210810B (en) Peptides for the treatment of pain and/or inflammation
IL217777A (en) Peptide for preparation of medicament for treatment of pain
IL216154A0 (en) Prevention and treatment of nosema disease in bees
EP2498796A4 (en) Treatment of heart disease
EP2400916A4 (en) Dental and medical treatments and procedures
PL2614832T3 (en) Diagnosis and treatment of preeclampsia
ZA201200017B (en) Formulations for the treatment of deeep tissue pain
EP2206714A4 (en) Agent for prevention and/or treatment of skin diseases
GB0904044D0 (en) The treatment of inflammatory disorders and pain
EP2387407A4 (en) Medicament for the treatment of pain and inflammation
HK1184169A1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
GB201107350D0 (en) Topical treatment of skin infection
IL213703A (en) Compounds for the treatment of pain and other diseases
EP2454372A4 (en) Treatment and diagnosis of immune disorders
EP2470268A4 (en) Purine-targeted diagnosis and therapy of wounds
EP2429559A4 (en) Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
PL2475361T3 (en) N-substituted benzenepropanamides for use in the treatment of pain and inflammation
HRP20151393T8 (en) USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
EP2124950A4 (en) Treatment of pain with naloxone
HU0900195D0 (en) Diagnosis and treatment of gluten-induced autoimmune diseases
EP2507266A4 (en) TREATMENT OF IgE-MEDIATED DISEASE
GB0724970D0 (en) Treatment and prevention of nuerodegenerative diseases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20111208

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

A4 Supplementary search report drawn up and despatched

Effective date: 20130715

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20130709BHEP

Ipc: A61K 31/19 20060101ALI20130709BHEP

Ipc: A61K 45/06 20060101ALI20130709BHEP

Ipc: A61P 43/00 20060101ALI20130709BHEP

Ipc: A61K 9/08 20060101ALI20130709BHEP

Ipc: A61K 36/258 20060101AFI20130709BHEP

Ipc: A61K 36/886 20060101ALI20130709BHEP

Ipc: A61K 41/00 20060101ALI20130709BHEP

Ipc: A61K 31/05 20060101ALI20130709BHEP

Ipc: A61K 47/14 20060101ALI20130709BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131203